Ambrx Biopharma Cayman, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2022.
  • Ambrx Biopharma Cayman, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $2.89M, a 53.6% increase year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.25M, a 47.3% decline from 2021.
  • Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.9M, a 874% increase from 2020.
  • Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $1.22M, a 33.5% decline from 2019.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $6.25M -$5.6M -47.3% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $11.9M +$10.6M +874% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.22M -$614K -33.5% Jan 1, 2020 Dec 31, 2020 20-F 2022-04-26
2019 $1.83M Jan 1, 2019 Dec 31, 2019 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.